Mpox outbreak in Rio de Janeiro, Brazil: a translational approach

Mpox is a zoonotic disease historically reported in Africa. Since 2003, limited outbreaks have occurred outside Africa. In 2022, the global spread of cases with sustained interhuman transmission and unusual disease features raised public health concerns. We explore the mpox outbreak in Rio de Janeiro (RJ) state, Brazil, in an observational study of mpox-suspected cases from June to December 2022. Data collection relied on a public healthcare notification form. Diagnosis was determined by MPXV-PCR. In 46 confirmed cases, anti-OPXV IgG was determined by ELISA, and seven MPXV genomes were sequenced. A total of 3095 cases were included, 816 (26.3%) with positive MPXV-PCR results. Most positive cases were men in their 30 s and MSM. A total of 285 (34.9%) MPXV-PCR+ patients live with HIV. Eight were coinfected with varicella-zoster virus. Anogenital lesions and adenomegaly were associated with the diagnosis of mpox. Females and individuals under 18 represented 9.4% and 5.4% of all confirmed cases, respectively, showing higher PCR cycle threshold (Ct) values and fewer anogenital lesions compared to adult men. Anti-OPXV IgG was detected in 29/46 (63.0%) patients. All analyzed sequences belonged to clade IIb. In RJ state, mpox presented a diverse clinical picture, represented mainly by mild cases with low complication rates and prominent genital involvement. The incidence in females and children was higher than usually reported. The observation of a bimodal distribution of Ct values, with few positive results, may suggest the need to review the diagnostic criteria in these groups.

Profiling the linear peptides of venom from the Brazilian scorpion Tityus serrulatus: structural and functional characterization

Scorpion venoms are a rich source of bioactive peptides, most of which are neurotoxic, with 30 to 70 amino acid residues in their sequences. There are a scarcity of reports in the literature concerning the short linear peptides found in scorpion venoms. This type of peptide toxin may be selectively extracted from the venom using 50% (v/v) acetonitrile. The use of LC-MS and MS/MS enabled the detection of 12 bioactive short linear peptides, of which six were identified as cryptides. These peptides were shown to be multifunctional, causing hemolysis, mast cell degranulation and lysis, edema, pain, and anxiety, increasing the complexity of the envenomation mechanism. Apparently, the natural functions of these peptide toxins are to induce inflammation and discomfort in the victims of scorpion stings.

Effect of environmental variables on the incidence of Visceral Leishmaniasis in Brazil and Colombia

Visceral Leishmaniasis (VL) is the most severe of the three forms of Leishmaniasis. In the Americas, Brazil and Colombia present more than 90 % of the cases in the region. Our aim in this research was to estimate the association of the incidence rate of Visceral Leishmaniasis with the following environmental variables: the percentage of area suitable for the vector Lutzomyia longipalpis, the episodes of La Niña and El Niño, the Brazilian and Colombian biomes. Epidemiological data were obtained from the Brazilian Notifiable Diseases Information System and the Colombian National Public Health Surveillance System. Environmental data were downloaded from the NASA Giovanni web app, the Modis Sensor database, and the meteorological agencies of Australia, Japan, and the United States of America. Records of the presence of Lu. longipalpis were obtained from public databases and previous studies. As a result, the incidence per 10,000 inhabitants with LEBS for each El Niño-Southern Oscillation (ENSO) episode showed the largest values during El Niño 2015–2016, mainly in Brazil's Northeast and Central regions and the Northeast region of Colombia. Compared with the Neutral 2012–2014 episode, the episodes of El Niño 2015–2016 and La Niña 2010–2011 showed an average increase in the monthly incidence rate of VL, and the average increase was higher during El Niño 2015–2016 (aIRR = 2.304 vs.1.453) We found a positive association between the incidence rate of VL and the El Niño 2015–2016 episode and an impressive% of area suitable for the vector Lu. longipalpis in the Amazon region.An increase of 1 % in the area suitable for the vector Lu. longipalpis leads to an average rise of 0.8 % in the monthly incidence rate of VL. Our study shows a possible association between VL incidence and ENSO, with the most considerable incidence rates observed during El Niño 2015–2016 in Brazil's Northeast and Central regions and the Northeast region of Colombia. The present study is very important to better understand the Visceral Leishmaniasis transmission dynamics.

Sex, Age, and Risk Group Variations among Individuals Infected with HIV, HTLV-1, and HTLV-2: Review of Data Records (1983­2017) from a Public Health Laboratory in São Paulo, Brazil

The inaugural AIDS Program in Brazil was established in São Paulo in 1983, with the Instituto Adolfo Lutz appointed for laboratory assistance. Subsequently, research on HIV infections and HIV/HTLV (HIV/HTLV-1 and HIV/HTLV-2) co-infections was conducted. This narrative review focuses on studies from the Immunology Department (1983­2017) that significantly influenced AIDS diagnosis or provided epidemiological data such as prevalence rates, sex, age, and risk factors. Twelve studies, encompassing over 8000 individuals, are discussed. During 1983­1985, nearly all AIDS cases were attributed to homosexual/bisexual men aged 31 years old. Subsequently, heterosexual men and women emerged as risk groups owing to intravenous drug use (IDU) and/or unprotected sexual intercourse with AIDS patients or multiple partners per year. From 1985 onwards, vertical transmission led to child infections. HIV/HTLV co-infection rates decreased over time, initially associated with male IDU, and in the 2010s with female IDU, and individuals aged >40 years. Trends in HIV and HIV/HTLV co-infections among younger men and women (<30 years of age) were observed from 2015 to 2017. The changing characteristics and risk groups for HIV and HIV/HTLV co-infections over the years underscore the necessity for ongoing public policies to prevent retrovirus transmission, particularly among adolescents and young adults. (AU)

Identification of apob variants in samples from the brazilian population with hypercholesterolemic phenotype

INTRODUCTION AND OBJECTIVES: Apolipoprotein B plays a crucial role in regulating plasma cholesterol by mediating the interaction of low-density lipoprotein (LDL) with LDL receptors in the liver. Inherited mutations in this gene may increase the risk of developing premature atherosclerotic cardiovascular disease, especially in individuals with familial hypercholesterolemia type 2 (FH2). The aim of this study is to identify APOB variants that may indicate pathogenicity in a sample of the Brazilian population using a data bank exome sequencing study by NGS in a Brazilian population phenotypically diagnosed by clinical and laboratory profile. This finding is going to improve genetic hypercholesteremia diagnosis. Casuistic, Material and METHODS: High quality DNA samples (n=300) were sequenced using an exon- targeted gene sequencing (ETGS) strategy to identify variants in FH-related genes. Pathogenicity classification was based on criteria established by the American College of Medical Genetics and Genomics (ACMG), also using information from ClinVar and pathogenicity scores from previous association studies. RESULTS and CONCLUSIONS: A total of 121 variants were identified in APOB, of which four are novel variants missense (p.Thr626Asn, p.Ile2750Thr, p.Gln2078Lys and p.Met4184Arg). After curating pathogenicity scores, variants were classified according to the ACMG criteria. Among them four as pathogenic or likely pathogenic (p.Pro2739Leu, p.His1923Arg, p.Pro994Leu and p.Pro877Leu), and 21 variants had uncertain significance. Additionally, 92 previously known variants with uncertain significance were classified as benign or likely benign. The results were submitted to Clinvar for actualization of pathogenicity and to improve the molecular diagnosis associating APOB variants with the clinical phenotype of hypercholesterolemia. Financing: FAPESP, CNPQ, CAPES.

Preditores de comportamentos de autocuidado em indivíduos com insuficiência cardíaca no Brasil / Predictors of self-care behaviors in individuals with heart failure in Brazil

OBJETIVO: Identificar preditores de comportamentos de autocuidado em indivíduos com insuficiência cardíaca no Brasil. MÉTODO: Estudo transversal com 405 pacientes com insuficiência cardíaca. Os comportamentos de autocuidado foram analisados através do Self-Careof Heart Failure Index (Índice de Autocuidado na Insuficiência Cardíaca). Características clínicas e sociodemográficas foram investigadas como preditores da manutenção do autocuidado, de sua administração, e da confiança, por meio de regressões logísticas. RESULTADOS: Os preditores da manutenção do autocuidado foram o número de filhos (p<0.01), a fração de ejeção do ventrículo esquerdo (p<0.01), sentimentos positivos sobre a doença (p=0.03), obesidade (p=0.02), e doença renal dialítica crônica (p<0.01). Os preditores de administração do autocuidado foram ter filhos casados (p<0.01) e apneia (p<0.01). Os preditores de confiança no autocuidado foram renda familiar (p<0.01), número de internações nos 12 meses anteriores (p=0.01), número de doses de medicação diárias (p<0.01), e sedentarismo (p<0.01). CONCLUSÃO: Encontrou-se alguns preditores associados aos comportamentos de autocuidado, de modo que educação intensiva e auxílio social deveriam ser oferecidos aos pacientes com essas características.

In-Hospital Management and Long-term clinical outcomes and adherence in patients with acute decompensated heart failure: primary results of the first brazilian registry of heart failure (BREATHE)

BACKGROUND: Heart failure (HF), a common cause of hospitalization, is associated with poor short-term clinical outcomes. Little is known about the long-term prognosis of patients with HF in Latin America. METHODS: BREATHE was the first nationwide prospective observational study in Brazil that included patients hospitalized due to acute HF. Patients were included during 2 time periods: February 2011-December 2012 and June 2016-July 2018. In-hospital management and 12-month clinical outcomes were assessed, and adherence to evidence-based therapies was evaluated. RESULTS: A total of 3013 patients were enrolled at 71 centers in Brazil. At hospital admission, 83.8% had clear signs of pulmonary congestion. The main cause of decompensation was poor adherence to HF medications (27.8%). Among patients with reduced ejection fraction, concomitant use of beta-blockers, renin-angiotensin-aldosterone inhibitors, and spironolactone numerical decreased from 44.5% at hospital discharge to 35.2% at 3 months. The cumulative incidence of mortality at 12 months was 27.7%, with 24.3% readmission at 90 days and 44.4% at 12 months. CONCLUSIONS: In this large national prospective registry of patients hospitalized with acute HF, rates of mortality and readmission were higher than those reported globally. Poor adherence to evidence-based therapies was common at hospital discharge and 12 months of follow-up.

Identification of APOB variants in samples from the brazilian population with hypercholesterolemic phenotype

BACKGROUND AND AIMS: Apolipoprotein B plays a crucial role in regulating plasma cholesterol by mediating the interaction of low-density lipoprotein (LDL) with LDL receptors in the liver. Inherited mutations in this gene may increase the risk of developing premature atherosclerotic cardiovascular disease, especially in individuals with familial hypercholesterolemia type 2 (FH2). The aim of this study is to identify APOB variants that may indicate pathogenicity in a sample of the Brazilian population using a data bank exome sequencing study by NGS in a Brazilian population phenotypically diagnosed by clinical and laboratory profile. This finding is going to improve genetic hypercholesteremia diagnosis. METHODS: High-quality DNA samples (n»300) were sequenced using an exon-targeted gene sequencing (ETGS) strategy to identify variants in FHrelated genes. Pathogenicity classification was based on criteria established by the American College of Medical Genetics and Genomics (ACMG), also using information from ClinVar and pathogenicity scores from previous association studies. RESULTS: A total of 121 variants were identified in APOB, of which four are novel variants missense (p.Thr626Asn, p.Ile2750Thr, p.Gln2078Lys and p.Met4184Arg). After curating pathogenicity scores, variants were classified according to the ACMG criteria. Among them four as pathogenic or likely pathogenic (p.Pro2739Leu, p.His1923Arg, p.Pro994Leu and p.Pro877Leu), and 21 variants had uncertain significance. Additionally, 92 previously known variants with uncertain significance were classified as benign or likely benign. The results were submitted to Clinvar for actualization of pathogenicity. CONCLUSIONS: These results improve the molecular diagnosis associating APOB variants with the clinical phenotype of hypercholesterolemia.

Factors associated with diet quality among Brazilian individuals with cardiovascular diseases

BACKGROUND: An individual's dietary pattern contributes in different ways to the prevention and control of recurrent cardiovascular events. However, the quality of the diet is influenced by several factors. The present study aimed to evaluate the quality of the diet of individuals with cardiovascular diseases and determine whether there is an association between sociodemographic and lifestyle factors. METHODS: This is a cross-sectional study carried out with individuals with atherosclerosis (coronary artery disease, cerebrovascular disease or peripheral arterial disease) recruited from 35 reference centres for the treatment of cardiovascular disease in Brazil. Diet quality was assessed according to the Modified Alternative Healthy Eating Index (mAHEI) and stratified into tertiles. For comparing two groups, the Mann-Whitney or Pearson's chi-squared tests were used. However, for comparing three or more groups, analysis of variance or Kruskal-Wallis was used. For the confounding analysis, a multinomial regression model was used. p < 0.05 was considered statistically significant. RESULTS: In total, 2360 individuals were evaluated: 58.5% male and 64.2% elderly. The median (interquartile range [IQR]) of the mAHEI was 24.0 (20.0-30.0), ranging from 0.4 to 56.0 points. When comparing the odds ratios (ORs) for the low (first tertile) and medium (second tertile) diet quality groups with the high-quality group (third tertile), it was observed that there was an association between diet quality with a family income of 1.885 (95% confidence intervals [CI] = 1.302-2.729) and 1.566 (95% CI = 1.097-2.235), as well as physical activity of 1.391 (95% CI = 1.107-1.749) and 1.346 (95% CI = 1.086-1.667), respectively. In addition, associations were observed between diet quality and region of residence. CONCLUSIONS: A low-quality diet was associated with family income, sedentarism and geographical area. These data are extremely relevant to assist in coping with cardiovascular disease because they enable an assessment of the distribution of these factors in different regions of the country.

Identification of pathogenic variants in the brazilian cohort with familial hypercholesterolemia using exon-targeted gene sequencing

Familial hypercholesterolemia (FH) is a monogenic disease characterized by high plasma low-density lipoprotein cholesterol (LDL-c) levels and increased risk of premature atherosclerotic cardiovascular disease. Mutations in FH-related genes account for 40% of FH cases worldwide. In this study, we aimed to assess the pathogenic variants in FH-related genes in the Brazilian FH cohort FHBGEP using exon-targeted gene sequencing (ETGS) strategy. FH patients (n = 210) were enrolled at five clinical sites and peripheral blood samples were obtained for laboratory testing and genomic DNA extraction. ETGS was performed using MiSeq platform (Illumina). To identify deleterious variants in LDLR, APOB, PCSK9, and LDLRAP1, the long-reads were subjected to Burrows-Wheeler Aligner (BWA) for alignment and mapping, followed by variant calling using Genome Analysis Toolkit (GATK) and ANNOVAR for variant annotation. The variants were further filtered using in-house custom scripts and classified according to the American College Medical Genetics and Genomics (ACMG) guidelines. A total of 174 variants were identified including 85 missense, 3 stop-gain, 9 splice-site, 6 InDel, and 71 in regulatory regions (3'UTR and 5'UTR). Fifty-two patients (24.7%) had 30 known pathogenic or likely pathogenic variants in FH-related genes according to the American College Medical and Genetics and Genomics guidelines. Fifty-three known variants were classified as benign, or likely benign and 87 known variants have shown uncertain significance. Four novel variants were discovered and classified as such due to their absence in existing databases. In conclusion, ETGS and in silico prediction studies are useful tools for screening deleterious variants and identification of novel variants in FH-related genes, they also contribute to the molecular diagnosis in the FHBGEP cohort.

Primary prevention of cardiovascular disease at community clinics in the state of Sao Paulo, Brazil: results from the epidemiological information study of communities

BACKGROUND: Primary prevention of cardiovascular disease (CVD) remains a major challenge, especially in communities of low- and middle-income countries with poor medical assistance influenced by distinct local, financial, infrastructural, and resource-related factors. OBJECTIVE: This a community-based study aimed to determine the proportion and prevalence of uncontrolled cardiovascular risk factors (CRF) in Brazilian communities. METHODS: The EPICO study was an observational, cross-sectional, and community clinic-based study. Subjects were living in Brazilian communities and were of both sexes and ≥18 years old, without a history of a stroke or myocardial infarction but presenting at least one of the following cardiovascular risk factors: hypertension, diabetes mellitus and hypercholesterolemia. The study was carried out in Brazil, including 322 basic health units (BHU) in 32 cities. RESULTS: A total of 7,724 subjects with at least one CRF were evaluated, and one clinical visit was performed. Mean age was 59.2 years-old (53.7% were >60 years old). A total of 66.7% were women. Of the total, 96.2% had hypertension, 78.8% had diabetes mellitus type II, 71.1% had dyslipidemia, and 76.6% of patients were overweight/obese. Controlled hypertension (defined by <130/80 mmHg or <140/90 mmHg) was observed in 34.9% and 55.5% patients among respective criteria, the rates of controlled blood glucose in patients taking antidiabetic medications was 29.5%, and among those with documented dyslipidemia who received any lipid-lowering medication, only 13.9% had LDL-c on target. For patients presenting three CRF less than 1.9% had LDL-c < 100 mg/dL once their BP and blood glucose were on target. High education level as associated with blood pressure (BP) target of less than 130 / 80mm Hg. The glucose and LDL-c levels on target were associated with the presence of hypertension and diabetes mellitus. CONCLUSION: In Brazilian community clinics, regarding most patients in primary prevention, the CRF such as BP, blood glucose, and lipid levels are poorly controlled, with a majority of patients not achieving guidelines/recommendations.

Ethnic differences in normal electrocardiographic findings in elite brazilian football players: b-pro foot ECG pilot study

INTRODUCTION: The 12-lead electrocardiogram (ECG-12) is a useful tool in the assessment of athletes. The prevalence of normal electrocardiographic findings in elite Brazilian football players (EBFP) of different ethnicities is not well described. PURPOSE: To compare the prevalence of normal ECG-12 findings in Caucasian, Mixed-race (MR), and Afro-Brazilian (AB) EBFP. METHODS: A multicenter cross-sectional descriptive study was conducted with exams performed on EBFP as a pre-participation assessment from February 18, 2002, through October 20, 2022. RESULTS: 4,363 EBFP from 51 professional clubs (from all five regions of Brazil; 15 states, and 21 cities), aged 15-35 years (median: 19 years; IQR: 16-23) were evaluated. 2,027 were Caucasians, 1,324 were MRs, and 1,012 were ABs. In general, we recorded 4,155 ECG-12 with normal variations (95.2%). Positive Sokolow-Lyon criteria for left ventricular hypertrophy was more prevalent in ABs (41.8%) than in Caucasians (33.4%), or MRs (32.7%). The prevalence of early repolarization in ABs (41.5%) was higher than in Caucasians (34.6%), or MRs (35.5%). The PR interval was longer in ABs (157.1 ms) than in Caucasians (151.4 ms), or MRs (153.3 ms), and the first-degree atrioventricular block was more frequent in ABs compared to MRs (4.2% vs. 2.3%, respectively). On the other hand, Caucasians had a higher prevalence of incomplete right bundle branch block (14.2%) than MRs (11.2%), or ABs (9.7%). In our sample, only three EBFP showed second-degree atrioventricular block Mobitz type I (0.07%; one Caucasian and two AB athletes). CONCLUSIONS: This is the first large study to compare the prevalence of ECG-12 findings in EBFP from different ethnic groups. Those of AB origin have a significantly higher prevalence of ECG-12 findings compatible with the athlete's heart than Caucasians and MRs.

Correlação entre o escore SAME-TT2R2 e o polimorfismo VKORC1: C. 174-136C>T (RS9934438) como preditores da qualidade da anticoagulação entre pacientes idosos brasileiros usuários de varfarina / Correlation between the SAME-TT2R2 score and the VKORC1:C.174-136C>T (RS9934438) polymorphism as predictors of anticoagulation quality among elderly Brazilian patients using warfarin

INTRODUÇÃO: A varfarina é um anticoagulante utilizado na prevenção e tratamento de doenças tromboembólicas. Nos idosos, a principal indicação é fibrilação atrial. O exame mais utilizado para controle da anticoagulação é o tempo de protrombina, através do cálculo da razão normalizada internacional (RNI), na faixa 2-3, que requerem um monitoramento especial devido a idade, dificuldades na adesão, polimedicação ou comorbidades. Embora seja conhecido que os fatores genéticos influenciam na resposta terapêutica, na maioria dos hospitais a farmacogenética ainda não é considerada no cálculo de ajuste de dose. Portadores do genótipo rs9934438 AA requerem menor dose comparado com genótipo AG ou GG. O escore SAMe- -TT2R2 obtido por meio de algumas variáveis visa predizer quais os pacientes em uso de varfarina atingirão taxas de INR aceitáveis e, por consequência, um tempo na faixa terapêutica (TFT) adequado. Apostolakis, propuseram e validaram o escore SAMe-TT2R2 (S=sexo; A =idade OBJETIVO: Visando estabelecer uma conduta terapêutica personalizada, o presente estudo tem como objetivo avaliar correlação entre o polimorfismo rs9934438 do gene VKORC1 e correlaciona-lo com o escore SAME-TT2R2 na predição da qualidade da anticoagulação em uso de varfarina. MÉTODOS e RESULTADOS: Foram incluídos 29 pacientes, idade de 81,72 (±4,07), de ambos os sexos e em uso de varfarina. A análise do polimorfismofoi realizada através da PCR em tempo real utilizando os reagentes do kit TaqMan™ Sample-to-SNP™ e o sistema de detecção TaqMan® SNP Genotyping Assay. As análises estatísticas foram realizadas utilizando o pacote SPSS v. 16.0 e nível de significância adotado foi de 5% e o Escore SAME-TT2R2 foi calculado após entrevista. Os Escores Chadsvasc2 = 4,34 (±1,17), Hasbled = 2,24 (±0,68) e SAME-TT2R2 = 2,31(±1,28), a dose semanal variou de 10 a 55 mg. Apesar de ser um estudo piloto, com baixo amostra, a distribuição dos genótipos está em equilíbrio gênico, segundo Hardy-Weinberg (AA=24,3%, AG=41,3%, GG= 34,4%). Os portadores do genótipo AA necessitaram de menor dose para atingir a TFT quando comparados aos portadores do genótipo GG: 26,6 versus 39,7 mg/semana, corroborando o resultado do SAME-TT2R2 = 2 no grupo AA comparado ao GG que foi de 3. CONCLUSÃO: Os resultados mostram que o polimorfismo rs9934438 está associado com a dose semanal de varfarina administrada aos pacientes idosos de pelo menos 30% e com correspondência ao Escore SAME-TT2R2 que demostrou um índice menor.

Revascularização percutânea em mulheres e seus resultados na prática de um grande hospital terciário brasileiro / Percutaneous revascularization in women and its results in the practice of a large Brazilian tertiary hospital

INTRODUÇÃO: As mulheres com doença arterial coronária (DAC) representam um desafio aos procedimentos de revascularização devido às características clínicas e anatômicas peculiares e maiores taxas de complicações hospitalares. Atualmente, a revascularização percutânea (RP) com stents farmacológicos (SF) apresenta excelentes resultados imediatos e tardios, mesmo em cenários mais desafiadores, como nas mulheres. OBJETIVOS: Avaliar os resultados imediatos e de médio prazo de mulheres com DAC submetidas à RP + SF num hospital terciário da rede pública. MÉTODOS: Estudo de coorte observacional, longitudinal, com coleta de dados retrospectiva e acompanhamento prospectivo, analisando todas as mulheres com DAC estável ou síndrome coronária aguda (SCA) e tratadas com RP com SF entre 01/ 2019 e 12/ 2020. Foram realizadas análises de regressão logística para determinar os fatores preditores de risco para eventos hospitalares e tardios e curvas de sobrevivência livres de eventos cardíacos e cerebrovasculares maiores (ECCM) pelo método de Kaplan-Meier. RESULTADOS: Foram incluídas 1146 mulheres, com média de idade de 64,4 anos, com alta prevalência de comorbidades (88% hipertensas, 85% dislipidêmicas, 52% tabagistas; 47,5% diabéticas, 14% com doença renal crônica - DRC). Fatores de risco não tradicionais para DAC foram detectados em 12%, além de outras doenças cardiovasculares (6.6%) e comorbidades gerais. SCA foi detectada em 69%, e a via radial utilizada em 59% dos casos; 31% foram submetidas à RP multiarterial, sendo 13% estagiadas. O sucesso ocorreu em 97,7% das pacientes, com baixa taxa de complicações (5,4%), e mortalidade hospitalar de 1,2%. 1047 pacientes foram acompanhadas com seguimento médio de 576,2 dias, sendo 86% livres de ECCM. Morte total ocorreu em 5.3%, sendo cardíaca em 3.5%, infarto em 7.7%, AVE em 0.8% e nova revascularização em 5.5%. Os fatores preditores para os desfechos hospitalares foram a presença de DRC [odds ratio (OR) 3.11; intervalo de confiança de 95%:1.49-6.2] e insucesso no vaso tratado (OR 1.2; IC 95%: 1.17-5.9). Admissão por SCA (OR 1.58; IC 95% 1.06-2.35) e presença de complicações hospitalares (OR 6.66; IC 95% 2.42-18.3) foram os preditores de risco para ECCM na evolução em médio prazo. CONCLUSÃO: A RP com SF em mulheres apresentou resultados bastante favoráveis, com altas taxas de sucesso e baixas complicações apesar da alta prevalência de comorbidades cardíacas e não cardíacas associadas e predomínio de SCA pré- procedimento. Esta e a presença de complicações hospitalares foram preditores de ECCM em médio prazo.

Impacto da pandemia de Covid-19 nos exames cardiológicos no Brasil: uma análise do SUS e da medicina suplementar / Impact of the Covid-19 pandemic on cardiological exams in Brazil: an analysis of the SUS and supplementary medicine

INTRODUÇÃO: a pandemia de COVID-19 ocasionou grande impacto no sistema de saúde brasileiro. Além da sobrecarga de pacientes infectados pelo virus, o risco de contaminação obrigou múltiplos serviços de saúde a interromper ou reduzir drasticamente a oferta de exames diagnósticos em cardiologia. O objetivo desse estudo foi avaliar o impacto da pandemia sobre a realização de exames cardiológicos no Sistema Único de Saúde (SUS) e na saúde suplementar. MÉTODOS: coletamos dados referentes aos exames de teste ergométrico, ecocardiograma (repouso e estresse; transtorácico e transesofágico), cintilografia (perfusão de estresse e repouso; avaliação de necrose; viabilidade), cineangiocoronariografia e ressonância magnética cardíaca realizados nos anos de 2019 e 2020 no SUS e no sistema suplementar (mesmos métodos acrescidos de tomografia para escore de cálcio e angiotomografia coronariana) em pacientes internados e ambulatoriais. Os dados foram coletados online a partir do DATASUS e da plataforma da Agência Nacional de Saúde (ANS) e os anos de 2019 e 2020 foram comparados. RESULTADOS: No ano de 2019, foram realizados no Brasil 10.647.379 exames diagnósticos cardiológicos no SUS e no sistema suplementar no Brasil; já no ano 2020, foram apenas 8.315.215 - redução de 2.332.164 exames ou queda de 21,9% em relação ao ano anterior. No SUS, a redução no número de exames foi de 781.529 (24,4%) no comparativo entre os dois anos; já na saúde suplementar, a queda foi de 1.550.635 exames (20,8%). Na análise nacional por método diagnóstico, observamos comportamento heterogêneo ao longo do biênio 2019/2020: teste ergométrico apresentou queda relativa de 28,1%, ecocardiograma 19%, cintilografia miocárdica 26,7% e cineangiocoronariografia 16,5%; já a ressonância magnética cardíaca apresentou aumento de 5% no período. Tendências heterogêneas também foram observadas na comparação entre os exames realizados no SUS e na saúde suplementar ao longo do período de análise. Dados de tomografia cardíaca (disponíveis somente na saúde suplementar) mostraram aumento de 36,7 mil exames em 2019 para 47,1 mil exames em 202 (aumento de 28,4%). CONCLUSÕES: a pandemia de COVID-19 ocasionou alteração importante na estratégia de investigação diagnóstica entre pacientes cardiológicos no Brasil no ano de 2020, com redução significativa no número de exames no SUS e na saúde suplementar e impacto heterogêneo conforme a modalidade diagnóstica. Esses resultados podem contribuir para o planejamento de ações no âmbito público e privado voltadas para a melhoria na investigação cardiológica nos próximos anos.

Evolução intra-hospitalar e tardia após primeiro infarto agudo do miocárdio: um estudo de mundo real comparando coortes de mulheres e homens no brasil, na rede colaborativa trinetx / In-hospital and late evolution after the first acute myocardial infarction: a real world study comparing cohorts of women and men in brazil, in the trinetx collaborative network

INTRODUÇÃO: Diversos estudos demonstram piores desfechos em mulheres após infarto agudo do miocárdio (IAM) quando comparados ao sexo masculino, mesmo após ajuste para covariáveis. As justificativas para essa desigualdade não são bem esclarecidas. Um fator inegável é a baixa representatividade feminina nos estudos clínicos randomizados e observacionais, e a consequente lacuna no conhecimento sobre as particularidades nessa população. No Brasil, apenas um registro comparou coortes de homens e mulheres após internação por síndrome coronariana aguda, com resultados conflitantes em relação à literatura global, mais extensa e robusta. OBJETIVO: Comparar, com base em dados de mundo real, a ocorrência de eventos cardiovasculares (ECV) entre mulheres e homensinternados por primeiro IAM em hospitais brasileiros. MÉTODOS: Estudo de coorte retrospectivo, com dados extraídos da plataforma global TriNetX, alimentada por prontuários eletrônicos de 13 instituições brasileiras, incluindo pacientes de ambos os sexos com diagnóstico confirmado de IAM pela classificação internacional de doenças (CID) versão 11, código I21. O desfecho primário avaliado foi o composto de óbito, choque cardiogênico (CC), edema agudo pulmonar, e parada cardiorrespiratória (PCR) ressuscitada durante internação hospitalar. Os desfechossecundários avaliados foram óbito, insuficiência cardíaca (ICC), ou hospitalização por novo IAM após 5 anos da alta hospitalar. Resultados plotados em Odds Ratio (OR) com intervalo de confiança (IC) de 95%, e teste de significância em 5%, e curvas de Kaplan-Meier com teste de log-rank para significância (Figura). Análise sobre procedimentos de revascularização miocárdica e ajuste após pareamento por escore de propensão serão apresentados a posteriori. RESULTADOS: O estudo incluiu 11.605 pacientes, com 7.442 homens (64,1%) e 4.163 (35,9%) mulheres. O desfecho primário ocorreu em 439 homens (5,9%) e 307 mulheres (7,4%). O sexo masculino foi associado à menor ocorrência do desfecho primário em relação ao feminino [OR 0,8 (0,68-0,92), p=0.02]. Após 5 anos, 435 homens (5,8%) e 309 mulheres (7,4%) apresentaram ICC [OR 0,77 (0,66-0,90), p=0.001], e 1.007 homens (13,5%) e 520 mulheres (12,5%) apresentaram novo IAM [OR 1,096 (0,98-1,23), p=0.112]. CONCLUSÕES: Nesta coorte brasileira de IAM, o sexo feminino foi associado à maior ocorrência de ECV (óbito, CC, edema agudo pulmonar e PCR ressuscitada) durante internação hospitalar e menor sobrevida livre de ECV após 5 anos do primeiro evento.

A Cross-sectional study on the prevalence and risk stratification of chronic kidney disease in cardiological patients in São Paulo, Brazil

ABSTRACT: Chronic kidney disease (CKD) provides a worse prognosis for patients with heart disease. In Latin America, studies that analyzed the prevalence and risk stratification of CKD in this population are scarce. We aimed to evaluate CKD prevalence and risk categories in patients of a public referral cardiology hospital in São Paulo, Brazil. This was a cross-sectional study based on a laboratory database. Outpatient serum creatinine and proteinuria results performed between 1 January 2021 and 31 December 2021 were analyzed. CKD was defined by estimated glomerular filtration rate (eGFR) 30 mg/g. A total of 36,651 adults were identified with serum creatinine levels (median age 72.4 [IQR, 51.0­73.6] years, 51% male). Among them, 51.9% had UACR dosage (71.5% with UACR < 30 mg/g, 22.6%, between 30­300 mg/g, and 5.9% with UACR > 300 mg/g). The prevalence of CKD was 30.9% (15.3% stage 3a, 10.2% stage 3b, 3.6% stage 4, and 1.7% stage 5), and the distribution of patients in the risk categories of the disease was: 52.0% with low-risk, 23.5%, moderate risk, 13.0%, high risk, and 11.2%, very high. In an outpatient setting, the prevalence of CKD in cardiological patients was almost three times (31%) that of the general population; about half of the individuals evaluated (48%) were not screened for an important risk marker (proteinuria), and approximately a quarter of these patients (24%) were in the high or very high CKD risk categories.

Coronary artery bypass grafting in young patients - a brazilian retrospective cohort study

BACKGROUND: The prevalence of early Coronary Artery Disease (CAD) (i.e., patients under 45 years) is increasing, which entails an equal rise in disability-adjusted life years due to disease burden. Risk factors in this population are not entirely elucidated. Hence, our objectives were to evaluate the clinical characteristics, risk factors, and outcomes in patients under 45 and over 45 years undergoing Coronary Artery Bypass Grafting (CABG). METHODS: We performed a retrospective-comparative cohort between patients under and over 45 years, who underwent CABG at Instituto Dante Pazzanese de Cardiologia, in São Paulo/Brazil, from 1999 to 2015. Patientsʼ characteristics were evaluated by Fisher Exact Test, and risk factors for in-hospital mortality were assessed by Stepwise Logistic Regression. Survival analysis was performed by Kaplan Meier and Log Rank Test. RESULTS: During the study timeframe, 8,889 patients underwent surgery and, out of those, 408 were young. The follow-up period ranged from 10 days to 257 months. Patients under 45 years were associated with higher rates of hypertriglyceridemia, current smoking, previous myocardial infarction and family history of coronary artery disease. Further, they presented higher rates of single vessel disease (11% versus 5.4%, p<0.001), with higher incidence of isolated occlusion of the left anterior descending artery (10.8% versus 5.1%, p<0.001). The younger group had a higher number of coronary artery bypass grafts (2.75±0.82 versus 2.6±0.88, p<0.001). Finally, they were also associated with lower in-hospital mortality (1.7% versus 5.1%, p=0.001). Survival estimates in 10 and 15 years among patients under 45 years were 91.7% and 87.7%, respectively, with an average lifespan of 237,21 months. CONCLUSION: Although hypertriglyceridemia, smoking and family history are well-recognized risk factors for CAD, they may play a more significant role in younger patients. Additionally, this study showed that CAD has a different clinical course in patients under 45 years, which urges the need to readdress how these patients are screened, evaluated and treated. To our knowledge, this is the first Brazilian study to assess this special population.